MFS
APLS

Mirabella Financial Services’s Apellis Pharmaceuticals APLS Stock Holding History

Mirabella Financial Services’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,078
Closed -$228K – 908
2025
Q4 		$228K Buy
+9,078
New +$213K 0.02% 566
2023
Q1 		– Sell
-25,326
Closed -$1.31M – 393
2022
Q4 		$1.31M Buy
+25,326
New +$1.34M 0.12% 123

Other funds holding APLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Mirabella Financial Services's APLS Position: Q1 2026 in Review

Mirabella Financial Services sold out of Apellis Pharmaceuticals (APLS) in Q1 2026, closing a stake of 9,078 shares — an estimated $228K sold.

Mirabella Financial Services first reported a position in APLS in Q4 2022 and held it in 2 quarters. The position peaked at $1.31M in Q4 2022. 323 funds tracked by Wall St. Rank hold APLS as of Q1 2026.

  • Mirabella Financial Services reported no remaining Apellis Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Mirabella Financial Services sold 9,078 Apellis Pharmaceuticals shares in Q1 2026, an estimated $228K.
  • Mirabella Financial Services first reported a position in Apellis Pharmaceuticals in Q4 2022 and held it in 2 quarters.
  • Mirabella Financial Services's Apellis Pharmaceuticals position peaked at $1.31M in Q4 2022.
  • 323 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q1 2026.

Based on Mirabella Financial Services's 13F filing for Q1 2026, filed 12 May 2026.